AI-generated summary
This review discusses photobiomodulation (low-power near-infrared light) and its link to nitric oxide signaling in blood vessels. The authors report that recent studies consistently show photobiomodulation improves endothelial dysfunction by increasing bioavailable nitric oxide in a dose-dependent manner. The abstract notes that the precise mechanisms remain unclear.
- Who or what was studied
- unclear
- Wavelengths
- 1000, 1700 nm
- Limits stated in the abstract
- The abstract states that the precise mechanisms of action of photobiomodulation are still elusive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1000-1700 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Nitric oxide, Near-infrared, Penetration depth, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.